UBS Group’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-18,392
| Closed | -$327K | – | 7435 |
|
|
2018
Q3 | $327K | Buy |
18,392
+11,883
| +183% | +$211K | ﹤0.01% | 3913 |
|
|
2018
Q2 | $90K | Sell |
6,509
-1,491
| -19% | -$20.6K | ﹤0.01% | 4642 |
|
|
2018
Q1 | $73K | Buy |
8,000
+908
| +13% | +$8.29K | ﹤0.01% | 4614 |
|
|
2017
Q4 | $30K | Buy |
7,092
+1,092
| +18% | +$4.62K | ﹤0.01% | 5284 |
|
|
2017
Q3 | $8K | Sell |
6,000
-380
| -6% | -$507 | ﹤0.01% | 6117 |
|
|
2017
Q2 | $10K | Sell |
6,380
-751
| -11% | -$1.18K | ﹤0.01% | 5861 |
|
|
2017
Q1 | $18K | Sell |
7,131
-9,491
| -57% | -$24K | ﹤0.01% | 5321 |
|
|
2016
Q4 | $42K | Buy |
16,622
+10,622
| +177% | +$26.8K | ﹤0.01% | 5049 |
|
|
2016
Q3 | $19K | Sell |
6,000
-3,099
| -34% | -$9.81K | ﹤0.01% | 5457 |
|
|
2016
Q2 | $29K | Buy |
9,099
+2,649
| +41% | +$8.44K | ﹤0.01% | 5108 |
|
|
2016
Q1 | $20K | Sell |
6,450
-5,606
| -46% | -$17.4K | ﹤0.01% | 5382 |
|
|
2015
Q4 | $48K | Buy |
12,056
+2,010
| +20% | +$8K | ﹤0.01% | 4788 |
|
|
2015
Q3 | $47K | Buy |
10,046
+3,946
| +65% | +$18.5K | ﹤0.01% | 4778 |
|
|
2015
Q2 | $32K | Sell |
6,100
-538
| -8% | -$2.82K | ﹤0.01% | 5126 |
|
|
2015
Q1 | $42K | Buy |
6,638
+638
| +11% | +$4.04K | ﹤0.01% | 4805 |
|
|
2014
Q4 | $38K | Buy |
+6,000
| New | +$38K | ﹤0.01% | 4960 |
|